Pharma Journalist -

Zentalis Pharmaceuticals, Inc. announced a clinical collaboration agreement with Eli Lilly and Company in which Zentalis will evaluate the combination of ZN-c5, the Company’s oral…
Read More...

Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, and Cyclica, whose AI-augmented, integrated platform enables…
Read More...

AstraZeneca has entered into a new global development and commercialisation agreement with Daiichi Sankyo Company, Limited (Daiichi Sankyo) for DS-1062, Daiichi Sankyo’s proprietary…
Read More...

Emergent BioSolutions Inc. announced that it has signed an agreement to provide contract development and manufacturing (CDMO) services for large-scale commercial drug substance…
Read More...

Sandoz announced the plans for a joint investment, together with the Austrian federal government, to strengthen the long-term future of integrated antibiotics manufacturing in Europe.…
Read More...

Moderna, Inc. announced that the Phase 3 study of its mRNA vaccine candidate (mRNA-1273) against COVID-19 has begun dosing participants. The Phase 3 study, called the COVE (Coronavirus…
Read More...

Pfizer Inc. and BioNTech SE announced the execution of an agreement with the U.S. Department of Health and Human Services and the Department of Defense to meet the U.S. government’s…
Read More...

Dynavax Technologies Corporation and Medigen Vaccine Biologics Corporation announced their collaboration to develop an adjuvanted vaccine candidate to protect against COVID-19. The…
Read More...

Grifols announced it has acquired 10% of Bloodbuy (BloodSolutions, LLC), a cloud-based marketplace that facilitates buying and selling of blood components in the U.S. Bloodbuy's…
Read More...

Arcturus Therapeutics Holdings Inc. announced a binding term sheet with the Israeli Ministry of Health to supply the Company’s COVID-19 vaccine candidate, LUNAR-COV19. The parties…
Read More...